MedNexus
2018年 · 第98卷第30期
MedNexus
- 全部
- 专家论坛
- 标准与规范
- 糖尿病基础与临床
- 临床研究
- 基础研究
- 新技术新方法
- 疑难病例析评
- 病例报告
In recent decades, diabetes has been widespread worldwide and its prevalence has been on the rise. The ultimate goal of focusing on diabetes is to reduce chronic complications caused by long-term hyperglycemia, especially cardiovascular events and cardiovascular deaths. However, research in the United States suggests that in the past 30 years or so, a reduction in all-cause death and cardiovascular death has only been observed in male diabetic patients, and no similar phenomenon has been found in women, suggesting that female diabetes may have some gender-related characteristics.
Honesty is an important symbol to measure the degree of civilization and progress of a society. Scientific research integrity is the cornerstone of scientific and technological innovation, the power source to promote the development of scientific undertakings, and an important benchmark to lead the progress of human civilization[
The ideal biomarker for diabetes needs to have high sensitivity and specificity, sufficient stability and convenient to establish standardized detection technology. In particular, sampling has little damage to patients, and significant changes in levels can be keenly detected in the early stage or even in the early stage of the disease, so as to accurately intervene in the early stage of individuals, delay or prevent the occurrence of diseases, and realize the advancement of the prevention and control barrier.
Anemia is more common in preoperative patients. If it is not treated effectively, it will affect the surgery and prognosis of patients. Therefore, timely diagnosis and treatment of preoperative anemia is very important. At present, preoperative anemia is not paid enough attention clinically. Usually, only blood transfusion is used to correct anemia or direct surgery without intervention, which not only increases the risk of perioperative blood transfusion and surgery, but also increases the incidence of postoperative complications and mortality. With the continuous and in-depth understanding of blood management of perioperative patients, relevant consensus and guidelines have been issued at home and abroad. In 2016, the safety and effect evaluation project team of joint replacement surgery released the "Accelerated Rehabilitation of Hip and Knee Arthroplasty in China-Expert Consensus on Diagnosis and Treatment of Perioperative Anemia", which provided guidance for perioperative anemia management in orthopedic surgery. However, preoperative anemia is not only limited to orthopedic surgery patients, but also common in other surgical departments. Therefore, we searched domestic and foreign literatures, combined with published relevant consensus and guidelines, and extensively consulted relevant professional experts to formulate this consensus, aiming at providing a basis for standardized diagnosis and treatment of preoperative anemia (this consensus does not include pediatric surgery patients).
A 21-year-old male was admitted to Peking Union Medical College Hospital on April 27, 2016 due to "intermittent nausea, vomiting and melena for 2 months". In March 2016, intermittent nausea and vomiting began, accompanied by diarrhea and black paste stool more than 10 times/d, with a maximum amount of 500 ml/time. Intermittent hyperthermia with asthenia. The hemoglobin was 34 g/L in other hospitals. Gastroscopy showed a submucosal bulge of the duodenal bulb with a smooth surface. Multiple superficial ulcers of the jejunum with active hemorrhage revealed by oral enteroscopy. Pathology of the jejunal mucosa showed chronic inflammation. Treatment with fluid rehydration, acid suppression, blood transfusion and antibiotics was ineffective. Then I went to our hospital for blood routine: white blood cells 5.9×109/L, lymphocytes 1.28×109/L, hemoglobin 84 g/L, platelets 281×109/L; Serum albumin 26 g/L, erythrocyte sedimentation rate 56 mm/1 h, high-sensitivity C-reactive protein 20.76 mg/L; Anti-nuclear antibody and anti-neutrophil cytoplasmic antibody were both negative; Blood lymphocyte culture plus interferon assay (T. SPOT-TB) A + B: 232 SFC/106MC. March 28 Chest CT (
本期目次

